Sun Sep 15 16:49:12 UTC 2024: ## DekaBank Increases Stake in IDEXX Laboratories, Boosting Confidence in Animal Health Company

**[City, State] -** DekaBank Deutsche Girozentrale, a prominent German financial institution, has increased its holdings in IDEXX Laboratories, Inc. (NASDAQ: IDXX) by 3.8% during the second quarter, as revealed in a recent filing with the Securities and Exchange Commission. The move signifies growing confidence in the animal health company, whose stock has been attracting attention from institutional investors.

DekaBank now owns 54,220 shares of IDEXX, representing approximately 0.07% of the company’s stock, valued at $26,721,000. This follows a trend of several other institutional investors, including Riverview Trust Co, Crewe Advisors LLC, Ridgewood Investments LLC, Institutional & Family Asset Management LLC, and DSM Capital Partners LLC, acquiring new stakes in IDEXX. Institutional investors currently own a significant 87.84% of the company’s stock.

Recent analyst ratings on IDEXX are mixed. While StockNews.com downgraded the company from “buy” to “hold,” Stifel Nicolaus and Piper Sandler lowered their target price on IDXX shares. However, BTIG Research initiated coverage with a “buy” rating and a $580.00 price target. Overall, IDEXX has a consensus rating of “Moderate Buy” and a consensus price target of $582.25, according to data from MarketBeat.

IDEXX Laboratories specializes in developing and distributing products for the veterinary, livestock, and water testing markets globally. The company’s recent earnings report for the second quarter, released on August 6th, showed revenue of $1 billion, slightly missing analyst estimates. However, the company experienced a 6.4% year-over-year revenue growth, showcasing its strong market presence.

IDEXX’s stock opened at $500.55 on Friday, reflecting its continued growth potential. With a market capitalization of $41.20 billion, the company remains a key player in the animal health industry, attracting interest from both institutional and individual investors.

Read More